Flowcytometry Panel - CSF for Hematolymphoid malignancies
As we continue to strive for better health, the microscopic world of our cells often holds the keys to understanding and combating diseases. Flow cytometry is a technique that allows us to explore this world, especially in the case of diseases such as hematolymphoid malignancies—cancers affecting our blood and lymphatic system.
Profile Name Flowcytometry Panel - CSF for Hematolymphoid malignancies
Sample Type Cerebrospinal Fluid (CSF)
Preparations Required No specific instructions related to fasting or water consumption are needed for this test. Do inform your doctor about any current medications or supplements you are taking.
Report Time 2 days
The Flow Cytometry Panel for Hematolymphoid Malignancies in Cerebrospinal Fluid (CSF) uses an array of markers like CD45, CD34, CD38, TdT, CD19, CD20, CD22, CD10, CD79a, Kappa, Lambda, CD1a, CD2, CD3, CD4, CD5, CD7, CD8, CD13, CD33, CD56, CD64, CD117, CD123, and MPO. By detecting and measuring these markers in CSF, it can provide pivotal information about the presence and progression of hematolymphoid malignancies.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Note: Home Sample Collection is only for Pathology lab tests.
Frequently Asked Questions
The panel measures the presence and amount of specific cellular markers in the CSF, helping in
identifying and characterizing hematolymphoid malignancies.
The frequency of this test is determined by your doctor, based on your diagnosis, response to treatment,
and potential recurrence of disease.
Normal values can vary since the test measures a wide range of cellular markers. Your results will be
interpreted in the context of your overall health and specific symptoms.
No specific precautions are required for this test. It's important, though, to inform your doctor about
any medications or supplements you are currently taking, as they could influence the test results.
The test results can be influenced by a variety of factors, including certain medications and underlying
health conditions. Some factors, such as lifestyle choices, can be modified, while others, such as
genetic predispositions, cannot be changed.
An abnormal test result should be discussed with a hematologist or oncologist, who can provide further
guidance based on your specific results and overall health.
The test involves collecting a CSF sample, which carries minor risks like bruising or infection at the
puncture site. Serious complications are rare.
An abnormal result does not necessarily mean you have a malignancy. Your doctor will interpret the
results based on your symptoms, medical history, and other test results.
Treatments may include chemotherapy, targeted therapy, immunotherapy, or stem cell transplantation,
depending on the type and stage of the malignancy.
Healthy lifestyle choices may support overall health and possibly influence treatment outcomes. However,
disease progression is primarily dictated by the type, stage, and treatment response.
Most hematolymphoid malignancies are not hereditary, but a small proportion can have a genetic component.
If you have a family history of such conditions, discuss this with your doctor.
Yes, this test can be performed during pregnancy. However, it's essential to inform your doctor if you
are pregnant.
No, flow cytometry does not involve radiation exposure.
Flow cytometry has revolutionized our understanding of hematolymphoid malignancies. By assessing the cellular markers in CSF, it offers a profound insight into these conditions, empowering us to plan and respond more effectively to the disease. This test is another significant step towards a future where these conditions are more comprehensively understood and efficiently managed.
